{"name": "BioPheresis",
 "permalink": "biopheresis",
 "crunchbase_url": "http://www.crunchbase.com/company/biopheresis",
 "homepage_url": "http://www.biopheresis.de",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@biopheresis.de",
 "phone_number": "49-6221-61891-01",
 "description": "",
 "created_at": "Sat Jul 03 13:23:47 UTC 2010",
 "updated_at": "Sat Jul 03 13:32:45 UTC 2010",
 "overview": "\u003Cp\u003EBioPheresis Technologies is a US Delaware corporation, and its wholly owned operating company, BioPheresis GmbH, incorporated in 2003, is located in Heidelberg, Germany. BioPheresis has developed a new patent protected blood treatment system designed to remove specific cancer-protecting immune-inhibitors from the blood.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[147,
       98],
      "assets/images/resized/0009/2368/92368v1-max-150x150.jpg"],
     [[147,
       98],
      "assets/images/resized/0009/2368/92368v1-max-250x250.jpg"],
     [[147,
       98],
      "assets/images/resized/0009/2368/92368v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "George",
      "last_name": "Rehm",
      "permalink": "george-rehm",
      "image":
       {"available_sizes":
         [[[129,
            150],
           "assets/images/resized/0025/9424/259424v1-max-150x150.jpg"],
          [[136,
            158],
           "assets/images/resized/0025/9424/259424v1-max-250x250.jpg"],
          [[136,
            158],
           "assets/images/resized/0025/9424/259424v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://localtechwire.com/business/local_tech_wire/venture/story/1161782/",
    "source_description": "Cary-Based Biopheresis Raises $8 Million To Back Cancer Treatment System",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 5,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Scandinavian Life Science Venture",
         "permalink": "scandinavian-life-science-venture-2",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0010/3593/103593v1-max-150x150.png"],
             [[250,
               47],
              "assets/images/resized/0010/3593/103593v1-max-250x250.png"],
             [[250,
               47],
              "assets/images/resized/0010/3593/103593v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "firstVentury Equity",
         "permalink": "firstventury-equity",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Im Neuenheimer Feld 519",
    "address2": "",
    "zip_code": "69120",
    "city": "Heidelberg",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        121],
       "assets/images/resized/0009/2369/92369v1-max-150x150.jpg"],
      [[250,
        202],
       "assets/images/resized/0009/2369/92369v1-max-250x250.jpg"],
      [[450,
        364],
       "assets/images/resized/0009/2369/92369v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}